SmartTRAK Life Sciences News and Analysis Blog

2 min read

Strong Gains with Room to Grow: Q421/FY21 AWC Market Recap

4/7/22 9:41 AM

Q421 AWC Header V3Advanced wound care delivers strong double-digit growth and still has room to grow.

The WW Advanced Wound Care markets regained their form in FY21 as wound care recovered globally after COVID-19 impacted FY20. Advanced Dressings delivered nearly double-digit growth, with Wound Biologics and External Devices also reporting excellent revenue growth vs FY20.

Among the many topics covered in detail in our comprehensive Q421/FY21 AWC Market Recap* are:

  • Complete Q421/FY21 AWC Market Overview
  • SmartTRAK's Expert Analysis and Insights
  • All Market News including Revenues, Data, Charts and Shares
  • Advanced Dressings Market Grows in Nearly Double-Digits as Wound Care Returns
  • Skin Substitutes/CTPs Drive Significant Wound Biologics Growth
  • Despite Lingering COVID-19 Headwinds sNPWT Continues Double-Digit Growth
  • Growth Analysis – WW Market Growth Driven by US Biologics Companies

US Skin Substitute/CTP revenue surged in Q421 and FY21, driven by strong growth in the Physician Office and among Amniotic Allografts. Single-use NPWT hit double-digit growth despite strong COVID-19 procedure cancellation headwinds and the Advanced Dressings market drove ...

Read the entire Q421/FY21 AWC Market Recap, including news, data, charts, company revenues, shares and our expert analysis*

*These links and the entire unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Learn More

SmartTRAK now offers Skin Substitutes (CTP) Site of Care. This module will make you an expert in Site of Care information for the Skin Substitutes market and includes market shares, 5-Year Growth Projections and Company & Product Performance across multiple sites of care. Download our PDF to get a preview of what's available!

Gary Delhougne
Written by Gary Delhougne

SmartTRAK GM, Wound. Licensed attorney with 20 years’ medical device and consulting experience in market access, health economics and policy roles at Smith & Nephew, Covidien, Avalere Health and Ernst & Young.

    Follow Us on Social Media

    Recent Articles